摘要 |
N1-acyl-N2-phenyl-1,3-diaminopropan-2-ols are disclosed which possess ulcer-inhibiting activities. Further disclosed are pharmaceutical compositions which are effective in the treatment and prophylaxis of ulcers and which comprise as a pharmacologically active ulcus-inhibiting ingredient N1-acyl-N2-phenyl-1,3-diaminopropan-2-ols, or a pharmaceutically acceptable acid addition salt thereof, and a pharmaceutically acceptable diluent. Further disclosed are processes for the preparation of the N1-acyl-N2-phenyl-1,3-diaminopropan-2-ols. |
申请人 |
KALI-CHEMIE PHARMA GMBH, |
发明人 |
LIEPMANN, HANS,;HUESCHENS, ROLF,;MILKOWSKI, WOLFGANG,;ZEUGNER, HORST,;HEINEMANN, HENNING,;WOLF, KLAUS-ULLRICH,;HELL, INSA,;HEMPEL, REINHARD, |